Characterization of Plasmodium methionine metabolism key enzyme by Marreiros, Maria Inês Moreira Oliveira Leite
2016 
 
UNIVERSIDADE DE LISBOA 
FACULDADE DE CIÊNCIAS 
DEPARTAMENTO DE BIOLOGIA VEGETAL 
 
 
 
 
 
 
 
 
 
Characterization of Plasmodium methionine 
metabolism key enzyme 
 
 
 
 
 
 
Maria Inês Moreira Oliveira Leite Marreiros 
 
 
MESTRADO EM BIOLOGIA MOLECULAR E GENÉTICA 
 
Dissertação orientada pela Doutora Vanessa Alexandra Zuzarte Luís (Instituto de 
Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa) e pela 
Professora Anabela Bernardes da Silva (Faculdade de Ciências da Universidade de 
Lisboa) 
 
 
  
 
  i 
 
ACKNOWLEDGMENTS 
 
Quero, em primeiro lugar, agradecer à Professora Doutora Maria Mota por me ter dado a 
oportunidade de realizar a minha tese de mestrado no seu laboratório. 
À Professora Anabela Silva pelo apoio e disponibilidade demonstrados ao longo de todo este percurso. 
Quero agradecer, em especial, à Vanessa. Obrigada por tudo o que me ensinaste sempre com tanta 
paciência, dedicação e carinho. Obrigada por toda a motivação constante, toda a compreensão, por 
todos os conselhos e por toda a confiança que depositaste em mim e no meu trabalho. O teu 
entusiasmo pela ciência e o modo como a praticas são realmente inspiradores. Obrigada sobretudo 
pelo apoio incondicional e pela amizade, foste sem dúvida a melhor orientadora que poderia ter tido.   
Quero desde já agradecer a todas as pessoas do laboratório. Obrigada por me terem recebido de 
braços abertos e por todo o vosso apoio. Obrigada por toda a ajuda, todos os conselhos, pela alegria e 
boa-disposição constante e por me terem sempre guiado quando me sentia perdida. Obrigada 
sobretudo pela amizade e por serem uma segunda família. Embora sejam todos muito importantes 
quero agradecer em especial a algumas pessoas que me são mais próximas: 
 
À minha Léninha, pela amizade e por todo o apoio e motivação constante. Obrigada por toda a ajuda 
com os WB, pelas inúmeras vezes que reveste a tese comigo, por todos os momentos de alegria e, 
principalmente, por todos os conselhos e por tudo o que me ensinaste sobre a vida. 
 
Ao Miguel, pela amizade incondicional. Obrigada por todo o apoio, toda a paciência e compreensão. 
Obrigada por teres percorrido este caminho sempre ao meu lado e, sobretudo, por seres o irmão que 
nunca tive! 
Ao Ângelo, por tudo o que me ensinaste sobre ciência e sobre a vida (e também sobre história!). 
Obrigada por todos os conselhos sábios nos momentos de maior indecisão, por toda a motivação, pela 
boa-disposição constante, pela tua amizade e principalmente por me conseguires fazer sempre sorrir 
(mesmo quando a vida sabia a ‘rosas de plástico’!).  
Ao João, por todo o apoio, por todos os conselhos e por todas as horas que perdeste a ajudar-me no 
microscópio. Obrigada por toda a disponibilidade que sempre demonstraste para me ajudar e, 
principalmente, pela amizade. 
À Ana Parreira, à Margarida Ruivo, à Inês Bento, à Maria Menezes, à Priscila e à Marta Machado por 
todas as palavras de força, por toda a preocupação que sempre demonstraram e pela amizade.  
 
 
 
 
ii  
 
Quero agradecer também à minha família e aos meus amigos. Sem o vosso apoio, a vossa força e 
motivação constante não teria conseguido. Obrigada por terem sempre acreditado em mim mesmo 
quando eu própria não acreditei. 
Aos meus pais e à minha irmã por todo o amor e apoio. Todas as palavras parecem escassas quando 
tento agradecer tudo o que fizeram e fazem todos os dias por mim. Não há palavras que consigam 
descrever o quão importante foi ter-vos a meu lado. Obrigada por toda a paciência que tiveram 
comigo, por toda a compreensão, por todo o vosso carinho. Obrigada por tudo o que ensinaram sobre 
a vida, por todos os valores que me transmitiram e por me terem dado sempre asas para voar e para 
seguir os meus sonhos. São sem dúvida os melhores e tudo o que sou hoje devo-o a vocês. Adoro-vos! 
À minha melhor amiga, Mariana, pela amizade incondicional ao longo destes últimos 11 anos. Obrigada 
por todo o teu apoio, por todas as conversas, por me mostrares sempre o lado melhor da vida e por 
nunca me teres deixado baixar os braços. Obrigada por estares sempre ao meu lado e por me 
mostrares que o irás estar sempre. Adoro-te. 
Ao André, por todo o amor. Não há palavras que descrevam a sorte que tenho em ter-te ao meu lado 
todos os dias. Obrigada pelo apoio, pela amizade, por todos os conselhos, por toda a força e motivação 
constante. Não há palavras que consigam agradecer toda a paciência que tiveste, todas as horas que 
perdeste a rever a tese comigo e toda a tua compreensão. És sem dúvida muito mais do que alguma 
vez esperei ter. ♥ you  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
  
  
 “There is inside you 
All of the potential 
To be whatever you want to be;  
All of the energy 
To do whatever you want to do.  
Imagine yourself as you would like to be,  
Doing what you want to do,  
And each day, take one step 
Towards your dream.  
And though at times it may seem too difficult 
to continue,  
Hold on to your dream.  
One morning you will awake to find 
That you are the person you dreamed of,  
Doing what you wanted to do,  
Simply because you had the courage 
To believe in your potential 
And to hold on to your dream.” 
   
  Donna Levine 
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ABSTRACT 
Malaria is a disease caused by protozoan parasites of the genus Plasmodium that are transmitted to 
humans by infected female Anopheles mosquitoes. Despite countless efforts toward eradication 
malaria still remains one of the most prevalent infectious diseases, constituting a major public health 
concern. The available antimalarial drugs are insufficient to control and eradicate malaria, mostly due 
to the emergence of drug-resistant parasites. Thus, the development of novel intervention strategies 
is critical to achieve eradication. As an obligatory intracellular pathogen, Plasmodium establishes close 
interactions with its host that are crucial to ensure parasite development and survival, one of such is 
the methionine metabolism. Methionine is an essential amino acid and, as for most living organisms, 
Plasmodium lacks the ability to synthesize methionine de novo. During the blood-stage of infection 
Plasmodium obtains methionine mainly through haemoglobin digestion. However, how Plasmodium 
obtains methionine during the liver-stage and how the parasite modulates the host cells in order to 
scavenge this essential amino acid is still unknown. The first step of methionine cycle is the synthesis 
of S-adenosylmethionine (SAMe) through a reaction catalyzed by the enzyme SAMe synthetase 
(SAMS). SAMe is a key metabolite in the methionine metabolism being the main biological donor of 
methyl groups for transmethylation reactions. SAMe is also a key intermediate in the transsulfuration 
pathway generating homocysteine (Hcy) which is metabolized into glutathione (GSH), being the last 
step of this pathway catalysed by glutathione synthetase (GS). GSH is a powerful antioxidant that in 
Plasmodium acts as one of the primary lines of the defense against the damage caused by reactive 
oxygen species (ROS), ensuring parasite survival. In this work we have explored the role of Plasmodium 
enzymes responsible for SAMe and GSH synthesis throughout its life cycle and in particular during the 
liver-stage of infection. The liver is a particular organ in the metabolism of methionine, namely in 
SAMe-dependent transmethylation reactions and in glutathione synthesis and storage. Thus, we 
hypothesized that while replicating inside hepatocytes, Plasmodium relies on its host to ensure a 
sufficient supply of these crucial metabolites. The data obtained in this study suggest that: 1) 
Plasmodium does not rely on its own SAMS enzyme while developing inside hepatocytes; 2) that the 
inhibition of SAMS activity during the blood-stage of infection leads to a low parasitemia, preventing 
the onset of cerebral malaria and 3) the deletion of GS-encoding gene results in the arrest at the oocyst 
stage, preventing transmission between the mosquito vector and the mammalian host. A detailed 
knowledge of Plasmodium methionine pathway provides promising tools for the design and 
development of novel antimalarial drugs. 
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SUMÁRIO 
A malária é uma doença causada por parasitas protozoários pertencentes ao género Plasmodium que 
são transmitidos aos humanos por mosquitos fêmea do género Anopheles. Apesar dos inúmeros 
esforços realizados na tentativa de erradicar a malária esta permanece ainda uma das doenças 
parasíticas mais prevalentes, constituindo um problema de saúde público. Os anti-maláricos 
disponíveis são insuficientes no controlo e erradicação da malária, devido sobretudo ao aparecimento 
de parasitas resistentes. Além disso, o escasso conhecimento acerca da biologia do parasita bem como 
das interações que este estabelece com o hospedeiro constituem uma barreira na luta contra a 
malária. Assim, o desenvolvimento de novas estratégias de intervenção torna-se crucial para conseguir 
a erradicação. Plasmodium é um patogénio intracelular obrigatório e, como tal, as interações que 
estabelece com o seu hospedeiro são essenciais para garantir o seu desenvolvimento e sobrevivência, 
nomeadamente as que estabelece ao nível do metabolismo da metionina. A metionina é um 
aminoácido essencial pelo que, tal como na maioria dos organismos, Plasmodium não tem capacidade 
para a sintetizar de novo.  Durante a fase sanguínea Plasmodium obtém metionina maioritariamente 
através da degradação de hemoglobina. Contudo, os mecanismos que Plasmodium utiliza para obter 
metionina durante a fase hepática, bem como para modular a célula hospedeira de modo a garantir 
um fornecimento suficiente deste aminoácido são ainda desconhecidos. O primeiro passo do ciclo da 
metionina consiste na síntese de S-adenosilmetionina (SAMe) numa reação catalisada pela enzima 
SAMe sintetase (SAMS). A SAMe é um metabolito essencial na via metabólica da metionina sendo o 
maior dador biológico de grupos metilo. A SAMe é ainda um importante intermediário na via da 
transsulfuração sendo convertida em homocisteína e subsequentemente metabolizada em glutationo, 
sendo o último passo desta via catalisado pela glutationo sintetase (GS). O glutationo é um 
antioxidante que em Plasmodium atua como uma das primeiras linhas de defesa contra espécies 
oxidativas. Neste trabalho explorámos o papel das enzimas de Plasmodium responsáveis pela síntese 
de SAMe e glutationo ao longo do seu ciclo de vida, com particular ênfase na fase hepática da infeção. 
O fígado tem um papel preponderante no metabolismo da metionina, nomeadamente nas reações de 
transmetilação dependentes de SAMe bem como na regulação da síntese e armazenamento do 
glutationo. Assim, a hipótese que propusemos testar é que enquanto replica no interior do hepatócito 
Plasmodium depende do hospedeiro para garantir a obtenção destes metabolitos essenciais.  Os 
resultados obtidos neste estudo demonstram que: 1) durante o seu desenvolvimento no fígado 
Plasmodium não depende da atividade da sua enzima SAMS; 2) a inibição da atividade da enzima SAMS 
durante a fase sanguínea da infeção resulta numa redução da parasitémia, prevenindo o aparecimento 
de malária cerebral e ainda que; 3) a deleção do gene que codifica para a enzima GS inibe o 
desenvolvimento dos esporozoítos, bloqueando assim a transmissão entre o vetor e o hospedeiro 
mamífero.  Assim, um conhecimento detalhado do metabolismo da metionina em Plasmodium fornece 
ferramentas promissoras para o desenvolvimento de novos anti-maláricos. 
 
 
Keywords: Malária, Plasmodium, Interação patogénio-hospedeiro, Metabolismo da metionina, ROS 
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RESUMO 
A malária é a doença parasitária com maior impacto no mundo estimando-se que por ano 214 milhões 
de pessoas são infetadas, resultando numa taxa de mortalidade de aproximadamente meio milhão de 
pessoas. A África subsariana é a área geográfica com maior taxa de incidência contudo, a malária é 
também endémica no Sudoeste Asiático, na América Latina e ainda nas regiões Mediterrânicas 
Orientais. O agente infecioso causador de malária é um parasita do género Plasmodium cuja 
transmissão entre hospedeiros é mediada por mosquitos fêmea do género Anopheles. Em seres 
humanos existem 5 espécies de Plasmodium capazes de causar infeção: P. falciparum, P. vivax, P. 
malariae, P. ovale e P. knowlesi.  Destas, P. falciparum é o parasita predominante em África sendo 
responsável pela manifestação mais severa da doença, a malária cerebral. Embora menos letal, P. vivax 
é a estirpe mais pandémica e caracteriza-se pela capacidade de gerar formas hepáticas dormentes, os 
hipnozoítos, que podem resultar em recidivas da doença. O ciclo de vida de Plasmodium é complexo, 
incluindo duas fases de desenvolvimento em hospedeiros distintos: o hospedeiro mamífero e o vetor, 
o mosquito Anopheles. O ciclo de vida de Plasmodium inicia-se quando um mosquito infetado se 
alimenta do sangue de um hospedeiro mamífero, depositando sob a sua pele centenas de 
esporozoítos. Os esporozoítos deslocam-se através da pele até entrarem num vaso sanguíneo 
migrando depois pela circulação em direção ao fígado onde, após atravessarem um determinado 
número de hepatócitos, estabelecem a fase hepática da infeção. Esta fase caracteriza-se por ser 
obrigatória e clinicamente silenciosa na qual o parasita se desenvolve rodeado por um vacúolo 
parasitóforo, denominado por forma exo-eritrocítica. No interior do hepatócito, o parasita inicia um 
ciclo de replicação assexuada denominado por esquizogonia no qual, cada parasita, origina milhares 
de merozoítos que são depois libertados na circulação sanguínea através de vesículas denominadas 
merossomas, iniciando assim a fase eritrocítica da infeção. Dentro do eritrócito os parasitas replicam 
mitoticamente desenvolvendo-se sequencialmente em anéis, trofozoítos e esquizontes. Os 
esquizontes diferenciam-se novamente em merozoítos levando à lise dos eritrócitos e 
consequentemente, ao aparecimento dos sintomas clínicos associados à doença. A nova descendência 
de merozoítos pode infetar novos eritrócitos, num ciclo que é reiniciado inúmeras vezes garantindo a 
progressão da infeção ou diferenciar-se nas formas sexuadas do parasita originando os gametócitos. 
Contudo, a divisão sexuada dos gametócitos apenas é possível no interior do mosquito. Assim, 
juntamente com a ingestão de sangue durante a picada do hospedeiro são também ingeridos os 
gametócitos. Estes migram até ao intestino médio onde se diferenciam em gâmetas masculino e 
feminino e sofrem fecundação, resultando na formação do zigoto. O zigoto sofre depois divisão 
meiótica adquirindo mobilidade sendo designado por oocineto, o qual migra pelo epitélio do intestino 
em direção à lamina basal onde se estabelece. Na lâmina basal o oocineto adquire uma forma globular, 
originando o oócisto. Este sofre um processo de maturação no qual se replica por mitoses sucessivas 
produzindo esporozoítos que, após rutura do oócisto, são libertados na hemolinfa. Os esporozoítos 
são formas móveis e alongadas, migrando depois em direção às glândulas salivares do mosquito onde 
estão aptos a infetar um novo hospedeiro, reiniciando assim o ciclo de vida. 
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Plasmodium tem uma capacidade replicativa notável atingindo taxas de crescimento enormes o que 
implica elevadas exigências nutricionais de modo a garantir a sobrevivência, nomeadamente de 
metionina. A metionina é um aminoácido essencial pelo que Plasmodium não tem capacidade para a 
sintetizar de novo. Sendo um parasita intracelular obrigatório, Plasmodium evoluiu no sentindo de 
assegurar as suas necessidades nutricionais derivando nutrientes a partir da célula hospedeira.  
Durante a fase sanguínea Plasmodium obtém aminoácidos maioritariamente através da degradação 
de hemoglobina da célula hospedeira. No entanto, esta contém apenas quantidades vestigiais de 
metionina não sendo suficiente para satisfazer as necessidades nutricionais do parasita. Assim, 
Plasmodium modula a célula hospedeira induzindo na sua superfície canais que asseguram a troca 
direta deste metabolito do citoplasma do eritrócito para o interior do parasita. Contudo, o modo como 
Plasmodium modula a célula hospedeira e em que medida é o crescimento do parasita dependente do 
hospedeiro durante a fase hepática não é ainda conhecido. Apesar de ser assintomática, esta fase 
caracteriza-se por um aumento exponencial no número de parasitas sendo também marcada por 
inúmeras interações estabelecidas entre parasita-hospedeiro, nomeadamente a nível metabólico. Este 
forte tropismo do parasita para o fígado humano em conjunto com uma correlação forte entre o 
metabolismo do hepatócito e o do parasita tornam a fase hepática da infeção de particular interesse 
para o desenvolvimento de novas estratégias que atuem antes do aparecimento dos sintomas clínicos 
associados à doença.  
 
O primeiro passo do ciclo da metionina é catalisado pela enzima metionina adenosiltransferase (MAT) 
- também conhecida por S-adenosilmetionina sintetase (SAMS) - e consiste na síntese de S-
adenosilmetionina (SAMe). A SAMe atua como co-substrato em inúmeras reações metabólicas sendo 
o metabolito percursor das vias de transmetilação, aminopropilação e transsulfuração.  Após ceder os 
seus grupos metilo a moléculas aceitadoras como DNA, RNA, lípidos e proteínas a SAMe é convertida 
em S-adenosilhomocisteína (SAH) que é, por sua vez, metabolizada em homocisteína. A homocisteína 
é então sequencial- e irreversivelmente convertida em cisteína e glutationo, sendo a última reação 
desta via catalisada pela enzima glutationo sintetase (GS). Dada a arquitetura do hepatócito e o papel 
preponderante do fígado: 1) na metabolização da metionina; 2) na mediação das reações de 
transmetilação dependentes de SAMe; bem como na 3) síntese e armazenamento de glutationo 
procurou-se neste presente trabalho testar se enquanto replica no interior do hepatócito, Plasmodium 
recorre ao hospedeiro para garantir um fornecimento suficiente destes metabolitos subvertendo 
assim esta via metabólica da célula hospedeira para garantir a sua sobrevivência. Para tal, gerou-se um 
parasita transgénico recorrendo à técnica do domínio destabilizador na qual a expressão de SAMS no 
parasita é regulada de acordo com a presença, ou não, de trimetoprima (TMP). A capacidade de 
Plasmodium se replicar e de estabelecer infeção na ausência de SAMS foi avaliada durante o seu 
desenvolvimento tanto no mosquito Anopheles bem como no hospedeiro mamífero in vivo, em 
modelo de roedores e in vitro, na linha celular HepG2. Os resultados obtidos in vivo sugerem que na 
ausência de SAMS (PbSAMS-DD – TMP) o desenvolvimento de Plasmodium durante a fase sanguínea 
é drasticamente afetado, resultando numa diminuição nos níveis de parasitémia. Além disso a ausência 
de SAMS leva a uma diminuição da virulência conferindo proteção contra a malária cerebral.   
 
 
 
  ix 
 
De seguida estudámos a importância de SAMS durante a fase hepática, in vitro. Os resultados obtidos 
demonstram que na ausência de SAMS os parasitas desenvolvem formas exo-eritrocíticas com igual 
tamanho e em igual número quando comparado com o grupo controlo (PbSAMS-DD + TMP), sugerindo 
assim que esta proteína não é essencial para o desenvolvimento nem para a replicação de Plasmodium 
durante este estadio da infeção. Os resultados obtidos in vivo estão em concordância com os obtidos 
in vitro, reforçando que durante a fase hepática Plasmodium não depende da sua enzima para 
completar o desenvolvimento e para estabelecer com sucesso a infeção. Durante o desenvolvimento 
de Plasmodium no mosquito tanto o número de oócistos como o de esporozoítos produzidos por 
parasitas que não expressam SAMS são idênticos ao obtido para o grupo controlo, sugerindo assim 
que esta enzima não é essencial durante esta fase do desenvolvimento.  
 
A infeção por Plasmodium induz no hospedeiro inúmeros mecanismos de defesa que resultam na 
produção excessiva de espécies reativas de oxigénio, que podem resultar na morte do parasita. Em 
contrapartida, numa tentativa de sobreviver, o parasita recorre às suas defesas nomeadamente a 
antioxidantes como o glutationo. Estudos anteriores demonstraram que, na ausência de y-GCS, a 
enzima limitante da reação de síntese de glutationo, Plasmodium não consegue completar o seu 
desenvolvimento nem estabelecer com sucesso a infeção no mosquito.  Tal como referido 
anteriormente, a síntese de glutationo envolve duas reações sendo que a GS catalisa o último passo. 
Assim, os resultados previamente obtidos para y-GCS permitiram-nos prever que a deleção da proteína 
GS em Plasmodium não iria surtir qualquer efeito no desenvolvimento do parasita durante a fase 
sanguínea.  Para testar a nossa hipótese, gerámos um parasita transgénico que não expressa o gene 
que codifica a enzima GS (Pbgs-). Os resultados obtidos in vivo permitiram então comprovar que, 
durante a fase sanguínea a enzima GS não é essencial para o desenvolvimento de Plasmodium. 
Contudo, o desenvolvimento de Plasmodium no mosquito é completamente inibido na ausência de 
SAMS, sendo a síntese de esporozoítos completamente bloqueada. Em suma, o conhecimento 
detalhado da via da metionina poderá contribuir para o desenvolvimento de novos anti-maláricos e 
também de novas estratégias que bloqueiem a transmissão de Plasmodium entre o vetor e o 
hospedeiro mamífero.  
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1. Malaria: a burden worldwide  
Malaria is one of the most severe infectious disease in the world with an incidence of 214 million cases 
and a mortality rate of 438 000 individuals in 20151. Despite several efforts for prevention and control, 
that greatly contributed to reduce the burden of the disease, malaria remains a public health concern. 
The vast majority of deaths occur in sub-Saharan Africa (90%) however, malaria is also endemic in 
South-East Asia, Latin America and Eastern Mediterranean regions2. Malaria is caused by intracellular 
protozoan parasites that belong to the genus Plasmodium of the phylum Apicomplexan. In humans, 
there are five species of Plasmodium that cause malaria, P. falciparum, P. vivax, P. malariae, P. ovale 
and P. knowlesi. Among them, P. falciparum is the most virulent and lethal being responsible for the 
severe malaria syndromes, the fatal manifestations of the disease3. In contrast, P. vivax despite being 
less virulent is the most widely distributed having the ability to generate hypnozoites – dormant forms 
of the parasite - that can lead to relapses of the disease4. 
 
Plasmodium life cycle 
Malaria parasites have a complex life cycle that relies on two obligatory hosts: the mosquito vector in 
which Plasmodium completes its sexual development, and the mammalian host where Plasmodium 
asexual development is completed (Figure 1.1). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 - Plasmodium life cycle: infection of the mammalian host and the mosquito vector. Infection of the mammalian 
host occurs when Plasmodium sporozoites are injected into the host skin by a female Anopheles mosquito, during a blood 
meal. Sporozoites enter the bloodstream and reach the liver, where each parasite invades a hepatocyte inside which grows 
and replicates into thousands of merozoites. Merozoites are then released in the bloodstream undergoing an asexual 
development inside the erythrocytes, a process that culminates with erythrocytes burst. Some parasites develop into sexual-
stage gametocytes that can be ingested by a female mosquito during a blood meal. Inside the mosquito midgut, gametocytes 
develop to female and male gametes that fertilize and generate the zygote. In the lumen of the midgut, the zygote 
differentiates into the ookinete that migrates and egresses from the basal lamina. Ookinetes become sessile and develop 
into oocysts that grow extracellularly and burst, releasing thousands of sporozoites that migrate to the salivary glands. 
Sporozoites can be transmitted during the next mosquito blood meal restarting Plasmodium life cycle (Image from Su et al, 
2007)5. 
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The infection of the mammalian host occurs during a blood meal, when an infected female Anopheles 
mosquito injects the Plasmodium parasite in its sporozoite form under the host skin6. Sporozoites 
migrate through the dermis to enter a blood vessel and reach the liver, where they undergo an 
obligatory stage of development. Once in the liver sporozoites migrate through several cells before 
infecting a final hepatocyte7. This culminates with the development of a specialized compartment 
around the sporozoite, the parasitophorous vacuole (PV). The liver-stage of infection is clinically silent 
and leads to a 10000-fold increase in parasite numbers8. Inside the PV each sporozoite develops into 
an exoerythrocytic form (EEF) that grows as the parasite replicates. EFFs undergo several nuclear 
divisions by schizogony and differentiate into thousands of erythrocyte-infective merozoites that 
egress from hepatocytes into the bloodstream initiating the blood-stage of the infection9,10. Once in 
the blood merozoites invade erythrocytes undergoing an asexual developmental process in which, 
each merozoite subsequently develops through ring, trophozoite and schizont-stages. Schizonts 
replicate into up to 32 daughter merozoites (depending on Plasmodium spp.) culminating with 
erythrocyte burst. The released merozoites infect new erythrocytes ensuring the progression and 
expansion of infection. This process is repeated umpteen times being responsible for the onset and 
the clinical symptoms of the disease11.  
During the blood-stage of development triggered by specific environmental factors, a small subset of 
parasites enter a sexual phase enabling transmission from the mammalian host to the anopheline 
vector. In this sexual stage, parasites develop into male and female gametocytes that during a blood 
meal can be taken up by a female Anopheles mosquito. Within the mosquito midgut, triggered by 
lower temperature, higher pH levels and other mosquito-specific factors, gametocytes develop into 
gametes. Gametes will subsequently undergo fertilization leading to the formation of the zigote12. The 
zygote develops into motile and invasive forms called ookinetes that cross the midgut epithelial cell 
layer, from the apical side towards the basal lamina. This step results in a reduction in ookinete 
numbers, owing to vector immune response. Ookinetes that survive become sessile and differentiate 
into oocysts. Oocysts are stationary spherical structures being the only extracellular developmental 
stage of Plasmodium life cycle. Through several divisions each oocyst develops into thousands of 
sporozoites that migrate to the mosquito salivary glands. If a Plasmodium-infected female mosquito 
bites a new human host, sporozoites are injected under the skin restarting the life cycle8. 
 
 
2. Methionine: an essential amino acid to sustain life 
Methionine is an essential amino acid for most living organisms, as such, there is no biosynthetic 
pathway for its de novo synthesis, meaning that it has to be obtained through the diet. As a sulphur-
containing amino acid, methionine is crucial for cell survival. A sufficient supply of methionine through 
the diet has a massive importance for the normal growth and development of mammals13. Indeed, 
genetic defects or abnormalities in the methionine metabolism are associated with cardiovascular and 
liver disease and with cancer14,15. After digestion of dietary proteins methionine is distributed, through 
the blood, to all tissues and cells where it is used for protein synthesis or as a substrate. While all the 
mammalian cells have the ability to metabolize methionine, the liver is the central organ where about 
50% of all dietary methionine is metabolized16. Methionine is the precursor of S-adenosylmethionine 
(SAMe), the main biological methyl group donor that is synthesized in the cytosol of every cell. SAMe 
is mostly consumed in methyl transfer reactions and has a key role in the methionine metabolism, 
being the precursor metabolite for transmethylation, aminopropylation and transsulfuration 
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pathways17,18. SAMe is a crucial regulator of multiple hepatic functions19 as such, the maintenance of 
a constant hepatic content of SAMe regardless of the daily intake of methionine has an enormous 
importance for the normal function of the liver, being the amount of SAMe that is synthesized and 
catabolized strictly regulated, ensuring homeostasis20. 
 
2.1 Methionine Metabolism in Mammals 
The metabolism of methionine in mammals consists in the transmethylation, the transsulfuration and 
the aminopropylation pathways (detailed in Figure 1.2). Methionine cycle starts with methionine 
conversion into SAMe, by the enzyme methionine adenosyltransferase (MAT) – also known as S-
adenosylmethionine synthetase (SAMS) - using ATP as a cofactor.  In mammals, two MAT isoenzymes 
were described: MAT I/III, encoded by the liver-specific mat1a gene and MAT II, expressed in all tissues 
and encoded by the mat2a gene13. As a methyl donor, SAMe transfers its methyl groups to acceptor 
molecules like DNA, RNA, proteins and phospholipids in a reaction catalyzed by specific 
methyltransferases (MTs). As a by-product, S-adenosylhomocysteine (SAH) is synthesized. SAH is a 
toxic intermediate that acts as a strong inhibitor of all transmethylation reactions by inhibiting MTs 
activity. The ratio between SAMe and SAH - methylation index – regulates the overall methylation 
capacity of the cell, being a sensitive indicator of cellular methylation status. In fact, a steep increase 
in SAH levels or decrease in SAMe levels can lead to disorders in the metabolism of methyl groups, 
which can consequently lead to cell death17. This means that the removal of excessive SAH is not only 
required but also critical for normal cell growth and survival.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 – Methionine metabolism in the mammalian liver. Methionine is converted to S-adenosylmethionine (SAMe) by 
methionine adenosyltransferase (MAT), using ATP as a co-substrate. SAMe can either be used to synthesize polyamines 
(aminopropylation pathway) or transfer its methyl groups to acceptor molecules leading to S-adenosylhomocysteine (SAH) 
synthesis (transmethylation). SAH is hydrolyzed to homocysteine (Hcy) and adenosine in a reversible reaction catalyzed by 
the SAH hydrolase (SAHH). Hcy can be either remethylated to salvage methionine or enter the transsulfuration pathway to 
be converted to cystathione and then to cysteine. Cysteine is then converted to ϒ-glutamylcysteine (ϒ-GC) and glutathione 
(GSH) in a two-step reaction catalyzed by ϒ-GC synthetase (ϒ-GCS) and GSH synthetase (GS), respectively. 
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SAH hydrolase (SAHH) is the only eukaryotic enzyme able to catalyze the reversible reaction in which 
SAH is hydrolyzed into adenosine and homocysteine (Hcy), completing the transmethylation pathway 
of the methionine metabolism21. Hcy occupies a branch point in the methionine cycle that according 
to biological requirements can be either re-methylated in order to regenerate methionine or 
irreversibly removed from methionine cycle, entering the transsulfuration pathway allowing for 
cysteine synthesis – the rate-limiting amino acid for glutathione (GSH) synthesis16,22. A condensation 
reaction between Hcy and serine, catalyzed by the enzyme cystathionine β-synthase (CβS), allows 
cystathionine synthesis. Cystathionine is then cleaved into cysteine that can be either used for protein 
synthesis or, due to its high reactivity, for GSH synthesis. GSH is synthesized in the cytosol of all 
mammalian cells in a tightly regulated manner. The synthesis rate of GSH is dependent on cysteine 
availability and in γ-glutamylcysteine synthetase (γ-GCS) activity – the rate-limiting enzyme - occurring 
via a two-step reaction23.  The first step is catalyzed by the enzyme y-GCS, allowing y-glutamylcysteine 
synthesis and the second step by the enzyme GSH synthetase (GS), a condensation reaction between 
y-glutamylcysteine and glycine that yields GSH24.  While all mammalian cells are equipped with the 
enzymatic machinery that allows methionine cycle, the transsulfuration pathway has a more limited 
distribution in mammalian tissues.  
 
2.2 Glutathione as a powerful tool in ROS detoxification 
The aerobic metabolism implies the production of ROS thus, a source of reducing equivalents is 
required by all cells to ensure the maintenance of an appropriate intracellular redox environment. The 
redox state of a cell is evaluated by the ratios between reduced and oxidized pyridine nucleotides - 
NAD(P)H/NAD(P)+ - and by the ratios between reduced and oxidized thiols, such as the ratio 
glutathione/glutathione disulphide - GSH/GSSG 25. These ratios and the intracellular levels of reactive 
oxygen species (ROS) are linked to the extent that, the activity of the enzymes involved in antioxidant 
processes depends on the redox state of the cell26. ROS play vital roles in cell physiology since that are 
involved in life cycle regulation, induction of signaling pathways and, moreover, in the stimulation of 
antioxidant responses27.  
However, if these antioxidant mechanisms fail to counterbalance the production of these reactive 
species the redox balance is lost and an oxidative stress occurs. In order to strictly regulate intracellular 
ROS levels aerobes evolved efficient antioxidant systems, including enzymatic scavengers of ROS - like 
superoxide dismutases - non-enzymatic molecules such as vitamins - vitamin E (tocopherol) and 
vitamin C (ascorbate) -  and peptides such as the tripeptide GSH. GSH is a tripeptide of glutamate, 
cysteine and glycine (y-L-glutamyl-L-cysteinyl-glycine) being the most abundant low-molecular weight 
thiol in mammals. It is present in all mammalian tissues and cells, being particularly high concentrated 
in the liver28. In eukaryotic cells 90% of the cellular GSH is found in the cytoplasm but it can also be 
found, at much lower levels, in the mitochondria and in the endoplasmic reticulum. This tripeptide can 
be found in its thiol-reduced form (GSH) or in its disulfide-oxidized form (GSSG). However, 
intracellularly, glutathione is maintained in its reduced form by the enzyme GSSG reductase29. GSH is 
a crucial regulator of many cellular events including xenobiotics detoxification, modulation of cell 
proliferation, DNA and protein synthesis and it is also the most abundant endogenous antioxidant. As 
a powerful antioxidant GSH plays a pivotal role in the maintenance of the intracellular redox status. 
Furthermore, it has high stability and is a non-toxic compound which makes GSH an outstanding redox 
buffer30.  
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3. Importance of methionine during Plasmodium infection 
As a rapidly multiplying organism Plasmodium has high nutritional and metabolic demands including 
amino acids, one of such the essential amino acid methionine. Like most living organisms Plasmodium 
cannot synthesize methionine, but its genome encodes all the key genes necessary for methionine 
catabolism, one MAT enzyme, several putative methyl transferases (MT), a SAHH, a SAMe 
decarboxylase (SDC) essential in polyamines synthesis and a GSH synthetase (GS)13.  During the 
intraerythrocytic stages malaria parasites can acquire amino acids for protein synthesis from: 1) 
degradation of host haemoglobin; 2) uptake of free amino acids present in the host plasma; or 3) 
through de novo synthesis31. Haemoglobin degradation occurs in a specialized acidic organelle - the 
food vacuole – and is the major source for amino acids acquisition during that stage of development. 
Once inside erythrocytes Plasmodium ingests and degrades up to 75% of the host cell haemoglobin 
into amino acids, detoxifying the toxic free haeme into haemozoin, a dark brown pigment32. 
Nevertheless, only less than 20% of these amino acids are used for parasite protein synthesis, being 
the majority exported to the extracellular medium33. Thus, not all parasite amino acid requirements 
are achieved through haemoglobin degradation. The amino acids isoleucine and methionine are 
absent, or at such low levels in human haemoglobin that an external source is required34.  
Mature erythrocytes are terminally differentiated cells that are unable to synthesize proteins de novo, 
hence erythrocytes nutritional demands are ensured by the presence of membrane transporters, 
namely the L-system35. The L-system is a nutrient transporter for apolar branched or aromatic amino 
acids, such as the essential amino acid methionine. However, in infected erythrocytes Plasmodium 
nutritional demands are not fulfilled by the narrow range and limited amount of amino acids 
transported by the L-system. To survive in this scarce environment Plasmodium parasites evolved 
mechanisms to modulate human erythrocytes permeability, in a way that the directly exchange of 
metabolites is allowed31. An outcome of this modulation is the induction of new permeability pathways 
(NPPs) in the membrane of the host erythrocyte (Figure 1.3). NPPs are endogenous dormant channels, 
characterized by their high permeability to low molecular weight solutes and also by their broad-
specificity and low-affinity. In Plasmodium-infected erythrocytes methionine is incorporated by the L-
system at similar amounts of that in uninfected erythrocytes36. However, there is an additional influx 
due to parasite-induced NPPs, which results in a 15-fold increase in the uptake of methionine by 
Plasmodium-infected erythrocytes37. The transport of neutral amino acids through these NPPs is 
unidirectional and is trans-stimulated by the opposite movement of other neutral amino acid. This 
putative transport ensures the uptake of amino acids that are absent in adult human haemoglobin and 
that are required for Plasmodium growth. However, this uptake implies the removal of amino acids 
that are easily obtained through haemoglobin degradation and whose excessive accumulation can lead 
to osmotic overload. This interplay between the host erythrocyte and the parasite for nutrient 
acquisition, energy production and waste removal is the basis of a successful infection34.  
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Figure 1.3 - Schematic representation 
of methionine transport in 
Plasmodium-infected erythrocyte. 
Plasmodium inability to obtain 
methionine from haemoglobin 
degradation within the host 
erythrocyte, is overtaken by the 
induction of new permeability pathways 
(NPPs) in the host cell membrane. This 
additional influx of methionine coupled 
with the amount of methionine that is 
transported by the L-system - an 
endogenous transporter of the 
erythrocyte - results in a 15-fold 
increase in methionine uptake by 
Plasmodium-infected erythrocytes 
(Image adapted from Cobbold et al, 
2011)34. 
 
Much less is known about Plasmodium dependency on methionine during the other developmental 
stages of its life cycle. During the liver-stage each sporozoite generates a progeny of thousands of new 
parasites. Thus, the availability of large amounts of nutrients is mandatory for Plasmodium 
development and survival. Inside hepatocytes Plasmodium lives and replicates in a haemoglobin-free 
environment meaning that an alternative source is required38. However, the metabolism of 
methionine during Plasmodium liver-stage development remains elusive.  
The interactions established between Plasmodium and the host inescapably lead to variations in the 
equilibrium between pro-oxidant and antioxidant molecules. This imbalance coupled with an excessive 
production of oxidizing species triggers an oxidative stress that can result in parasite death. The role 
of oxidative stress during malaria infection is still uncertain and some authors suggest a protective 
role, whereas others propose a close relation to the physiopathology of the disease39. Despite that, 
recent studies suggest that the excessive synthesis of ROS together with an oxidative stress play a 
pivotal role in the development of systemic complications associated to malaria40. Plasmodium 
infection inevitably leads to an increased oxidative stress both in the mammalian host as well as in the 
mosquito vector. In the mammalian host, oxidative stress occurs mostly due to: 1) the generation of 
hydroxyl radical (OH·) in the liver which can damage molecules like DNA, proteins and lipids leading 
consequently, to apoptosis41; and 2) due to the pro-oxidative environment of the erythrocyte. The 
erythrocyte has a high content of oxygen and iron, the key elements of the Fenton reaction - one of 
the major source of ROS production. Furthermore, the toxic free haeme that is released from digested 
haemoglobin inescapably leads to oxidation of Fe2+ into Fe3+ and to the release of superoxide anions, 
contributing also to an increased oxidative stress26,40. In fact, results obtained by Atamna et al. 
demonstrated that during the erythrocytic stage of infection, P. falciparum-infected 
erythrocytes produce twice more OH• radicals and H2O2  when compared to normal erythrocytes42. 
During the mosquito-stage of development due to the innate immune response of the vector, 
Plasmodium is also exposed to a high oxidative stress mainly during ookinete and sporozoites 
development, which results in relevant parasite losses26. In order to survive and succeed in these 
oxidative environments, Plasmodium evolved efficient antioxidant systems namely superoxide 
dismutases and thioredoxin-dependent peroxidases. However, Plasmodium lacks catalase and 
glutathione peroxidases which is counterbalanced by the presence of a fully functional glutathione 
redox system43.  
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Plasmodium heavily depends on methionine to complete a successful development, as evidenced by 
a severe impairment in parasite development when perturbations in the methionine cycle, or in any 
of its branches (transsulfuration and aminopropylation) occur44,45. This dependence on methionine is 
more remarkable during the erythrocytic stages of Plasmodium life cycle, resulting in a 15-fold increase 
in methionine influx-rate into infected erythrocytes.  Since there is a close connection between 
Plasmodium metabolism and the onset of the disease, unravelling the pathways and the mechanisms 
involved in the metabolism of this essential amino acid may be a rational and promising tool for 
developing both prophylactic agents and new chemotherapies against malaria16. Given the key role of 
the liver in: 1) methionine metabolism; 2) SAMe-dependent transmethylation reactions; and in 3) GSH 
synthesis and storage, the main aims of the present study focused the characterization of the 
importance of two main enzymes involved in the methionine metabolic pathway of Plasmodium: 1) 
GSH synthetase (GS) that is responsible for the de novo synthesis of glutathione and; 2) S-
adenosylmethionine synthetase (SAMS) which allows SAMe synthesis, a crucial metabolite in the 
methionine cycle.  
For this purpose, we will use the rodent malaria parasite P. berghei which, despite its phylogenetic 
distance, is analogous to human and primate malaria parasites sharing essential aspects as biology, 
physiology and life cycle. Additionally, P. berghei do not pose direct harm to humans and in vivo 
infected livers are directly accessible for analysis46. The availability of efficient reverse genetics 
technologies for P. berghei coupled with an ability to study and analyse its development throughout 
Plasmodium life cycle, make this species one of the greatest model to analyse parasite gene 
function47,48.  Thus, we will characterize the role of P. berghei GS and SAMS enzyme during the 
mosquito-stage and in both the blood- and liver-stage in vivo, using rodent models and in vitro, using 
cell lines.  
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 MATERIALS AND METHODS 
1. Ethics Statement 
All in vivo protocols were approved by the internal animal care committee of Instituto de Medicina 
Molecular and were performed according to the national and European regulations.  
 
2. Mice and Parasites 
Balb/c and C57BL/6J mice (6-8 weeks of age, female or male) were purchased from Charles River® 
Breeding Laboratories and housed in the Rodent Facility of IMM. 
Wild-type Plasmodium berghei (P. berghei) ANKA strain was obtained from the MR4 repository 
(Manassas, Virginia). Transgenic P. berghei parasite lines, namely GSH synthetase knockout (Pbgs-), 
SAMS conditional knockdown (PbSAMS-DD) and SAMS-green fluorescent protein (GFP) tagged 
(PbSAMS-GFP), were generated in our laboratory. Asexual blood-stage parasitic forms were 
maintained through passage of infected blood in mice. All recombinant P. berghei parasite lines carry 
the human dihydrofolate reductase (hdhfr) gene cassete that confers resistance to pyrimethamine, 
allowing the selection of recombinant parasites. Confirmation of transgenic parasites genotype, 
construct integration at the desired genomic loci and elimination of WT locus were assessed by 
performing a polymerase chain reaction (PCR). To that end, blood from the infected mice tail vein was 
collected in 200µL of 1x PBS and genomic DNA (gDNA) was isolated using the NZY Blood gDNA Isolation 
Kit (NZYTech), according to manufacturer’s guidelines. The PCR conditions used for genotyping were 
equivalent for all parasite lines and consisted of an initial denaturation at 95oC for 10 min, followed by 
an amplification for 40 cycles of: 10 sec at 95oC, 30 sec at 50 oC and 1 min at 68 oC. Amplification was 
followed by an additional extension step at 68 oC for 10 min. Sequences of primers used for genotyping 
are provided in Table 1, Annexes section. Stabilisation of PbSAMS-DD fusion protein throughout 
infection was achieved in vivo, by administration of trimethoprim (TMP) to mice (0.25 mg/ml of TMP 
in drinking water) and to mosquitoes (0.50 mg/mL of TMP in the mosquito food) or in vitro, to HepG2 
hepatoma cells (0.5 or 5mg/mL of TMP in culture medium). The time of the treatment was set 
according to the experimental protocol. 
 
3. Mosquitoes 
Anopheles stephensi (A. stephensi) mosquitoes were obtained from the breeding facility at IMM and 
both housing and infections were performed at IMM. Mosquitoes were housed at 20oC, 80% relative 
humidity and fed ad libitum with 10% glucose supplemented with 2% paraminobenzoic acid (PABA). 
Female mosquitoes were infected through feeding on mice infected with P. berghei ANKA WT, Pbgs-, 
PbSAMS-DD or PbSAMS-GFP parasites. 
 
3.1 Midguts dissection 
To assess oocysts number and size, midguts were dissected in 1x PBS at day 12 or 16 (Pbgs-) post 
mosquito infection and incubated with mercurochrome 0.1% (in H2O) for 10 minutes. Stained midguts 
were washed in 1x PBS, mounted on glass slides and immediately analysed by light microscopy using 
the Leica DM2500 microscope (10x objective). To compare ROS levels, midguts were incubated with a 
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2 µM solution (in DMSO) of the general oxidative stress indicator 6-carboxy-2',7'-
dichlorodihydrofluorescein diacetate (Carboxy-H2DCFDA from Molecular Probes) for 20 minutes at 
room temperature (RT) under dark conditions. After incubation, midguts were rinsed in 1x PBS, 
mounted on a glass slide and immediately analysed by fluorescence microscopy using the Leica 
DM5000 B microscope (10x objective). Comparison of fluorescent levels between different conditions 
was performed as the same camera exposure times were used. 
 
3.2 Salivary glands dissection 
Sporozoites for infection were obtained by dissection of infected salivary glands 21 and 28 (Pbgs-) days 
post mosquito infection. Salivary glands were dissected in Dulbecco’s Modified Eagle’s Medium 
(DMEM) and sporozoite number was assessed by light microscopy, using an improved Neubaeur cell 
counting chamber (depth 0.1 mm).  Sporozoites were used for in vitro infection of HepG2 hepatoma 
cells or for in vivo infection of mice. 
 
4. Parasite infections 
  In vivo infections 
For liver-stage experiments mice were infected through intravenous (i.v.) retro-orbital injection of 
5x104 sporozoites while for blood-stage experiments mice were infected through i.v. injection of 103 
sporozoites. To assess parasite liver load, livers were harvested 48 hours post-infection (hpi). To assess 
parasitemia levels in the blood throughout infection, thin blood smears fixed in 100% methanol were 
stained with Giemsa (10% v/v). Prepared slides were allowed to dry overnight before imaging and 
quantification was preformed using the Leica DM 2500 microscope (100 x oil objective) 
 
4.2 In vitro infection 
Liver-stage in vitro infections were performed in HepG2 hepatoma cells cultured in DMEM, 
supplemented with 10% fetal bovine serum, 2mM glutamine, 100 U/mL penicillin and streptomycin 
and maintained in a 5% CO2 humidified incubator at 37oC. For P. berghei infection, 6 X 104 HepG2 cells 
were platted (per well) in a 24-well culture plate and infection was performed 24 h post-seeding with 
3 x 104 salivary gland sporozoites. Two hours after infection, culture medium was supplemented with 
0.3% fungizone and infection was proceeded until suitable.  
 
5. RNA isolation and analysis by RT-qPCR 
Mosquito tissue: To isolate RNA from midguts and salivary glands, infected mosquitoes were dissected 
in 1x PBS supplemented with 1x Ribonuclease Inhibitors (NZY Tech).  Tissue lysis was performed by 
adding 1mL of PureZOL RNA isolation reagent (BioRad®). 
Mouse Blood: Blood from mice infected with synchronous parasites was collected at developmentally 
relevant time points post infection, by cardiac punction, allowing for isolation of RNA from ring- (6 hpi 
and 10 hpi), trophozoite- (14 hpi and 18 hpi) and schizont-stage (22 hpi) parasites. Infected blood was 
lysed by adding 1mL of TRIzol® LS Reagent (ThermoFisher scientific). 
10 | MATERIALS AND METHODS 
  
Mouse liver tissue: To extract RNA from mouse liver, whole livers were harvested 48 hpi in 1 mL of 
PureZOL RNA isolation reagent. Zirconia/Silica beads (1 mm) were added and tissue was disrupted 
using the Mini Bead Beater for 90 seconds.  
Hepatoma cells: HepG2 cells were lysed at developmentally relevant time points post infection, 
through addition of 1mL of PureZOL RNA isolation reagent directly to the well. 
For RNA extraction, chloroform was added to the lysates (240 µL chloroform per 1 mL of 
PureZOL/TRIzol) followed by vigorously vortex for 15 seconds and an incubation step at RT for 5 
minutes. Samples were then centrifuged at 12000 x g for 15 minutes at 4oC allowing phase separation. 
The upper aqueous phase was collected and 100% ethanol (1.5x volume) was added to precipitate 
RNA. All subsequent steps were performed using the NZYtech Total RNA Isolation Kit, according to 
manufacturer’s instructions. cDNA synthesis was performed using 1 µg of RNA and the NZY First-Strand 
cDNA Synthesis kit (NZYtech) according to manufacturer’s instructions. PCR conditions used for cDNA 
synthesis were: 25°C for 10 min, 55°C for 30 min and 85°C for 5 min. Isolated cDNA was used to perform 
a quantitative reverse transcription-PCR (RT-qPCR) in a 10 µL reaction mix, containing 1 μL of sample 
cDNA. For each experimental condition negative controls were performed, either without RNA or 
reverse-transcriptase enzyme. For relative quantification of Pbsams expression levels, 
adenylosuccinate lyase (PBANKA_0304300) and serine-tRNA ligase (PBANKA_0615400) expression 
levels were used for normalization, whereas for infection load Pb18S rRNA levels were normalized 
against mouse hypoxanthine guanine phosphoribosyltransferase (hprt) housekeeping gene (ΔCt). The 
RT-qPCR conditions used consisted of an initial denaturation at 95°C for 5 min followed by 
amplification for 40 cycles at 95°C for 3 sec and at 60°C for 30 sec, with fluorescence acquisition at the 
end of each extension step. Gene expression values were then calculated based on the ΔΔCt method 
using the mean of control group as calibrator to which all other samples were compared. Primer pairs 
used to detect the target gene transcripts are listed in Table 1, Annexes section. 
 
6. Immunofluorescence assays 
6.1 PbSAMS localisation studies 
Mouse blood: For blood-stage experiments, blood smears from PbSAMS-GFP-infected mice were fixed 
in 4% PFA (in PBS) for 10 min. Fixed cells were washed in 1x PBS and then permeabilized in 0.1 % Triton 
X-100 (in PBS) for 10 min. Blocking was then performed in 3% BSA (in PBS) for 30 min.  
Hepatoma cells: For liver-stage experiments in vitro, HepG2 hepatoma cells  cultured in coverslip were 
fixed in 4% PFA for 10 min, rinsed in 1x PBS and then permeabilized in 0.1% Triton X-100 for 10 min. 
After permeabilization, cells were blocked in 3% BSA for 30 minutes.  
Mosquito tissue: For mosquito-stage experiments PbSAMS-GFP-infected midguts and salivary glands 
were dissected in 1x PBS and DMEM, respectively. Midguts were fixed for 20min and salivary glands 
for 10min in 4% PFA. Fixed tissue was washed in 1x PBS, permeabilized in 0.1% Triton X-100 for 10 min 
and then blocked in 3% BSA for 30 min. 
After blocking and permeabilization samples were incubated in the following primary antibodies: goat 
anti-PbUIS4 (1:400, from Sicgen) and mouse anti-HSP70 (1:400, produced in house), for 2 hours at RT. 
The secondary antibodies used were: rabbit anti-GFP monoclonal antibody conjugated to Alexa Fluor 
488 (1:400, from Thermo Fisher scientific), donkey anti-goat conjugated to Alexa Fluor 568 (1:400, 
from Life Technologies) and donkey anti-mouse conjugated to Alexa Fluor 647 (1:400, from Jackson 
ImmunoResearch Laboratories). DAPi (1:1000, from Sigma) was used for nuclear staining. Incubation 
with secondary antibodies was performed for 1 hour at RT. Samples were mounted with Fluoromount-
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GTM (from Southern Biotech) and prepared slides were allowed to dry overnight before imaging. All 
images were obtained by fluorescence microscopy using the Zeiss Axio Observer microscope.  
 
6.2 PbSAMS-DD stabilisation by TMP treatment 
For PbSAMS-DD stabilisation verification, blood-stage and liver-stage in vitro samples were processed 
as described above (section 6.1) with exception of the antibodies employed for PbSAMS detection. 
Additionally, PbSAMS stabilisation during the liver-stage was also assessed in vivo. For this, the median 
liver lobe was collected and fixed in 4% PFA for 2 hours at RT, washed in 1x PBS and then sliced into 
40-µm-thick sections using the Vibratome VT 1000S (Leica). Fixed lobes were blocked in 3% BSA and 
permeabilized in 0,3% Triton X-100 for 3 hours at RT. Samples were incubated overnight at 4oC in the 
following primary antibodies: mouse anti-HA (1:400, from Covance), goat anti-PbUIS4 (1:400, from 
Sicgen) and rabbit anti-PbBip (1:400, from Thermo Fisher scientific). The secondary antibodies used 
were: donkey anti-mouse conjugated to Alexa Fluor 488 (1:400, from Jackson Immonoresearch), 
donkey anti-goat conjugated to Alexa Fluor 568 (1:400, from Life Technologies) and donkey anti-rabbit 
conjugated to Alexa Fluor 647 (1:400, from Jackson ImmunoResearch Laboratories). For nuclei staining 
DAPi (1:1000 from Sigma) was used. Incubation with secondary antibodies was performed for 1 hour 
at RT. Samples were mounted with Fluoromount-GTM and prepared slides were allowed to dry 
overnight before imaging. All images of PbSAMS-DD stabilisation were obtained by confocal 
microscopy using the Zeiss LSM 710 microscope. 
 
7. Parasite pellet extraction for Immuno-blotting 
All steps of parasite pellet extraction protocol were performed at 4o C to minimize protein degradation 
and all centrifugations were executed at 1000 x g for 10 min. Mice were sacrificed at day 10 post 
infection and 1mL of blood was collected by cardiac punction. The blood was washed in 10mL of 1x 
PBS and the pellet of packed erythrocytes was resuspended in 0.15% saponin and centrifuged. The 
parasite pellet obtained after lysis was washed in PBS containing 1x Proteinase inhibitor cocktail 
(Roche® cOmplete Protease inhibitor tablets, EDTA free). Parasite pellet was then resuspended in 
parasite pellet lysis buffer (4 % SDS; 0.5 % Triton X-114 in 1x PBS), incubated on ice for 10 min, 
centrifuged at 21000 x g for 10 min and the supernatant was collected. Total protein content was 
determined using the Bio-Rad protein assay kit according to manufacturer’s instructions, as standards 
different concentrations of bovine serum albumin (BSA) were used. Protein samples diluted in 5x SDS 
sample buffer (NZYTech) were denatured at 95º for 10 min and resolved in an 8% polyacrylamide gel 
(SDS-PAGE). Proteins were blotted into a nitrocellulose membrane by wet transfer at 200mA for 2 
hours. Primary antibody, mouse anti-HA antibody (1:1000, from Covance) was incubated overnight at 
4oC. Secondary antibody, anti-mouse horseradish peroxidase (HRP)-conjugated (1:10000, Santa Cruz 
Biotechnology) was incubated at RT for 1 hour. Signal detection was obtained using Luminata 
Crescendo Western HRP substrate (Merck Milipore®) and the ChemiDoc XRS+ Gel Imaging System (Bio-
Rad®). Protein band quantification was performed on Image Lab software (version 5.0). 
8. Statistical analysis 
Statistically significant differences between two different groups were analysed using the Mann–
Whitney test. p < 0.05 were considered statistically significant. Significances are represented in the 
figures as follows *p < 0.05; **p< 0.01, ***p< 0.001. All statistic tests were performed using GraphPad 
Prism 5.0 software. 
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  RESULTS 
 
Part I: Importance of Plasmodium berghei glutathione synthetase 
(PbGS) during the different stages of the life cycle 
Plasmodium is a rapidly multiplying organism that undergoes a complex life cycle between two 
different hosts – a life style that entails a rapid adaptation to the external milieu. It is well described 
that during the different stages of the life cycle, Plasmodium is continuously exposed to high levels of 
ROS and oxidative stress. If not tightly regulated ROS can lead to deleterious effects resulting in 
parasite death. During the blood-stage of the infection the majority of ROS produced arise from 
haemoglobin digestion and free-haeme release within the PV of the parasite. Within the anopheline 
vector, Plasmodium is also exposed to massive amounts of ROS. Inside the midgut ookinetes survival 
is crucial for the establishment of a new parasite generation, for further production of sporozoites and 
consequent transmission to the mammalian host. The mosquito midgut is a harsh environment for 
Plasmodium and during that stage oxidative stress and ROS arise mostly from: 1) the innate immune 
response of the vector; 2) Plasmodium metabolic switching from glycolysis to oxidative 
phosphorylation for energy production, resulting in relevant parasite losses49. If produced in excessive 
amounts ROS are toxic and harmful to Plasmodium, being ookinete and sporozoite forms the most 
affected. To sustain life in this noxious environment, Plasmodium depends on its antioxidant defenses. 
In fact, Plasmodium is adapted to cope and withstand in this toxic environment as evidenced by its 
ability to fully develop within two completely different hosts40. One of Plasmodium primary lines of 
defense against these oxidative species is the tripeptide GSH. Thus, given the major role of GSH in ROS 
detoxification together with the high amounts of ROS that arise from infection, we decided to study 
the importance of glutathione synthetase (GS) during Plasmodium development.  
 
 
1. Generation of a Pbgs knockout parasite line  
To study the importance of GS during Plasmodium growth and development, GS-deficient P. berghei 
lines (Pbgs-) were generated. The GS locus was disrupted by double crossover homologous 
recombination and the GS-encoding gene (gs) was deleted and replaced by the human dihydrofolate 
reductase (hDHFR) – a resistance cassete that allows for selection upon administration of 
pyrimethamine (Figure 4.1 A). Recombinant clones were obtained by limiting dilution of erythrocytes 
in a way that each mouse was infected with one single recombinant clone. Infected mice were treated 
with pyrimethamine in order to eliminate non-transgenic parasites in vivo. Mice parasitemia was 
assessed by counting GIEMSA-stained thin blood smears.  
It has been described that knocking-out γ-GCS-encoding gene had no significant effect in growth and 
multiplication of blood-stage Plasmodium parasites, in vivo50. As γ-GCS is the enzyme upstream to GS 
in the transsulfuration pathway and the rate-limiting enzyme of glutathione synthesis, we predicted 
that the deletion of gs will not have any effect in Plasmodium development and survival during that 
stage of development.  
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We observed that wild-type (WT) and Pbgs- parasite multiplication rate was similar during parasite 
exponential growth in the blood-stage of infection (data not shown). Thus, the successful generation 
of transgenic P. berghei knockout lines (Pbgs-) suggests that GS is not essential for the development of 
blood-stage parasites. Correct integration of the desired construct and the absence of WT parasites 
was confirmed by genotyping PCR (Figure 4.1 B). Two independent parasite clones, from two 
independent transfections were selected. 
  
Figure 4.1– Pbgs is not essential during the blood-stage of infection allowing for gene deletion. (A) Double crossover 
recombination strategy for generation of a P. berghei gs knockout line (Pbgs-).  (B) Genotyping PCR confirming a clonal 
population of Pbgs- parasites. Lane 1: detection of WT Pbgs locus; Lane 2: detection  of knockout construct integration locus. 
 
2. GS is essential during the mosquito-stage development of Plasmodium 
We then proceed with the characterization of GS function during Plasmodium development within the 
mosquito vector. For that purpose, Anopheles stephensi mosquitoes were infected with either WT or 
Pbgs- parasites. To evaluate the importance of GS in oocysts development, midguts were dissected 12 
and 16 days post mosquito infection. Midguts were stained with mercurochrome and oocyst number 
was determined by light microscopy.  Results obtained show that gs deletion resulted in a decrease in 
the number of Pbgs- oocysts in comparison to WT parasites (Figure 4.2 A). In addition, analysis of 
mercurochrome stained oocysts showed a marked reduction in Pbgs- oocysts size (Figure 4.2 B). To 
evaluate the ability of Pbgs- oocysts to develop and produce viable sporozoites, salivary glands were 
dissected at days 21 and 28 post mosquito infection. The results obtained show that sporozoites (spz) 
formation is completely impaired in Pbgs- parasites (WT spz number = 52 000 ± 8 000; Pbgs- spz number 
= 0; N=3). Thus, oocyst developmental arrest caused by the lack of GS results in an impairment in 
sporozoites formation.  
Plasmodium is exposed to high levels of ROS during the mosquito-stage being the tripeptide GSH 
crucial in ROS detoxification and therefore, in the maintenance of the redox equilibrium. Thus, we 
hypothesized that the absence of viable oocysts and sporozoites may result from Pbgs-  parasites 
inability to synthesize GSH and consequently, to detoxify ROS. 
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Figure 4.2– PbGS is essential for Plasmodium 
oocyst development and sporozoite 
production. (A) Quantification of oocyst 
number in WT- or Pbgs--infected midguts 
stained with mercurochrome and imaged at day 
12 and 16 post infection, using a light 
microscope. Each symbol represents an 
individual mosquito midgut. Horizontal lines 
represent the mean number of oocysts. 
Statistical significance was determined by the 
Mann Whitney U test, *p <0.05, ***p<0.001.  
(B) Representative pictures of oocysts size in 
midguts from WT- (upper) and Pbgs-- (bottom) 
infected mosquitoes, stained with 
mercurochrome at day 12 dpi and imaged using 
a light microscope. Arrows indicate oocysts. 
Scale bar - 50µm. N=3 
 
 
 
 
It has been described that blood meal-derived haeme leads to a decrease in ROS levels within the 
midgut of Aedes aegypti mosquitoes51. To test the effect of a blood meal on ROS levels in Anopheles 
stephensi midgut we analysed ROS levels in female mosquitoes fed with 10% glucose (sugar) or with 
blood. For this purpose, non-infected midguts from sugar- and blood-fed mosquitoes were dissected 
and incubated for 20 minutes in a 2µM solution of the oxidant sensitive probe 6-carboxy-2',7'-
dichlorodihydrofluorescein diacetate (carboxy – H2DCFDA).  Carboxy-H2DCFDA is a chemically 
reduced, acetylated form of fluorescein that is rapidly converted to a green-fluorescent molecule when 
its acetate groups are removed by intracellular esterases, resulting in an increased oxidation through 
ROS activity, within cells (Figure 4.3 A-C). Midguts integrity and the presence of blood in blood-fed 
midguts were confirmed by light microscopy (Figure 4.3 A) and ROS levels were analysed by 
fluorescence microscopy. The images show a strong CM-H2DCFDA fluorescence signal in midguts from 
sugar-fed when compared with blood-fed mosquitoes, indicative of high ROS levels (Figure 4.3 B).  
 
Then we tested if decreasing ROS levels within Pbgs--infected midguts would rescue the oocyst 
development phenotype, allowing for Pbgs- oocysts full maturation and further differentiation in 
sporozoites. To that end, Anopheles stephensi female mosquitoes were fed either with sugar or with 
blood every 48 hours, until the end of the experiment. Midguts were dissected at day 12 post mosquito 
infection and stained with mercurochrome for further evaluation of oocyst number and size by light 
microscopy. Results obtained show that the decrease in ROS levels by blood-feeding do not rescue the 
oocyst developmental arrest phenotype. Blood-feeding of Pbgs--infected female mosquitoes had no 
significant effect in oocysts development both in size as in number, when compared to the sugar-fed 
control (Figure 4.3 C, D).  
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Figure 4.3 – Inhibition of ROS production in the midgut does not rescue oocyst developmental arrest in Pbgs- parasites.  
(A-C) Representative pictures of sugar-fed (upper panels) or blood-fed (bottom panels) mosquito midguts 48 hours after the 
blood meal. (A) Midgut integrity and presence of blood in the lumen of blood-fed midguts assessed by light microscopy. Scale 
bar - 50µm. (B) Non-infected midguts from sugar- and blood-fed mosquitoes analysed for ROS levels through staining with 
the oxidant-sensitive probe carboxy-H2DCFDA (2µM) and analysed by fluorescence microscopy. Scale bar - 50µm (C) 
Representative picture of oocysts size in Pbgs—infected midguts from sugar- and blood-fed mosquitoes stained with 
mercurochrome and imaged by light microscopy at day 12 post infection. Scale bar - 100µm (D) Quantification of oocyst 
number in WT- or Pbgs--infected midguts from sugar- and blood-fed mosquitoes stained with mercurochrome and imaged at 
day 12 post infection, using a light microscope. Each symbol represents an individual mosquito midgut. Horizontal lines 
represent the mean number of oocysts. Statistical significance was determined by the Mann Whitney U test, ***p<0.001. 
N=3  
 
Salivary glands were dissected 21 post infection for assessment of sporozoite production. As before, 
no sporozoites were obtained both in sugar- or in blood-fed Pbgs- infected mosquitoes (data not 
shown). Altogether, the results obtained show that the absence of glutathione leads to an impairment 
in Plasmodium development during the mosquito-stage, being Pbgs- development completely blocked 
at the oocyst stage. The consequent inability to produce sporozoites compromises the transmission 
from the mosquito vector to the mammalian host, preventing further characterization of the role of 
GS during the liver-stage of development. Overall, these results highlight the importance of GS and 
consequently, GSH in the development and establishment of a successful Plasmodium transmission 
between the two hosts. 
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Part II: Importance of Plasmodium berghei SAMS enzyme during the 
different stages of the life cycle 
 
1. Expression and localisation of PbSAMS during the different developmental 
stages of Plasmodium berghei life cycle 
To characterize the importance of Plasmodium berghei SAMS enzyme (PbSAMS) in Plasmodium growth 
and replication we started by analysing the expression - both at mRNA and protein level - and 
localisation of PbSAMS during the liver-, mosquito- and blood-stage of Plasmodium infection. Analysis 
of Pbsams relative gene expression during Plasmodium life cycle was performed by RT-qPCR using 
specific primers to Pbsams. To assess Pbsams expression during the blood-stage of infection a RT-qPCR 
was performed on cDNA synthesized from total RNA, extracted from blood infected with tightly 
synchronized parasites available in the laboratory. Gene expression was analysed during ring- (4hpi 
and 10hpi), trophozoite- (14hpi and 18hpi) and schizont- (22hpi) stage parasites development. The 
results show that PbSAMS mRNA levels are higher immediately after invasion of erythrocytes during 
ring-stage parasites development, decreasing during development into trophozoite-stage to later 
increase during its differentiation into schizonts (Figure 4.4 A).  
 
 
Figure 4.4 –Pbsams mRNA is expressed throughout all stages of P. berghei life cycle. Quantification of Pbsams mRNA by RT-
qPCR (A) in blood-stage parasites: rings, trophozoites and schizonts; (B) in the mosquito-stage parasites: young-oocysts (day 
5pi), mature-oocysts (day 13pi) and salivary glands sporozoites (day 21pi) and (C) in the liver-stage at different times post 
HepG2 infection with P. berghei ANKA sporozoites. Pbsams expression levels were normalized against two P. berghei 
housekeeping genes, adenylosuccinate lyase and serine-tRNA ligase. Error bars represent SEM. Rng: Ring; Troph: Trophozoite; 
Schz: Schizont; Ooc: Oocysts; Spz: Sporozoites. N=3  
 
To extend investigation of Pbsams expression to the mosquito-stage, P. berghei -infected midguts and 
salivary glands were isolated. A RT-qPCR was performed allowing for quantification of Pbsams 
transcripts in young- and mature- midgut oocysts dissected at day 5 and 13 post infection, respectively 
and salivary gland sporozoites dissected at day 21 post infection.  
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Data obtained show that Pbsams has a low expression during oocysts development (young- and 
mature- oocysts) however, transcription of Pbsams gene increases 25-fold during sporozoites 
development (Figure 4.4 B). Lastly, for assessment of Pbsams expression during the liver-stage of 
infection, HepG2 hepatoma cells were infected with P. berghei sporozoites and isolated at relevant 
developmental time points post infection. The results show that expression of Pbsams mRNA is higher 
immediately after sporozoites invasion of HepG2 cells (6hpi) and decreases as intra-hepatic 
development progresses through sporozoite transformation (12hpi), replication (24 and 36hpi) and 
merozoite formation (48hpi; Figure 4.4 C). Altogether, the results obtained show that Pbsams is 
constitutively expressed through all the life cycle, being transcription levels particularly high in 
sporozoites. 
 
Protein localisation studies were performed by using a previously generated transgenic P. berghei line, 
expressing a C-terminal green fluorescent fusion protein of PbSAMS (PbSAMS-GFP). PbSAMS 
localisation during the different erythrocytic stages was assessed by immunofluorescence assay (IFA) 
of PbSAMS-GFP-infected blood smears, using the anti-GFP antibody. Further analysis by fluorescence 
microscopy showed that PbSAMS is expressed during all stages of erythrocytic development, exhibiting 
cytolosolic distribution and partially co-localising with Plasmodium endoplasmic reticulum protein Bip 
(PbBip; Figure 4.5).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5– PbSAMS is a cytoplasmic protein that partially co-localises with Plasmodium endoplasmic reticulum protein 
Bip during the blood-stage of infection. Widefield microscopy images of blood-stage PbSAMS-GFP parasites, rings, 
trophozoites and schizonts, stained with the anti-GFP antibody for detection of SAMS-GFP protein and anti-Bip antibody for 
endoplasmic reticulum detection. DAPI was used for nuclei staining. Scale bar - 5 µm  
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PbSAMS localisation was then investigated during the mosquito-stage, both in oocysts and 
sporozoites. PbSAMS-GFP-infected mosquito midguts and salivary glands were dissected at days 12 
and 21 post mosquito infection, respectively. Fluorescence microscopy analysis showed that during 
oocysts and sporozoites development, PbSAMS co-localises with the P. berghei heat-shock protein 70 
(PbHSP70) to the parasite cytoplasm (Figure 4.6). 
 
 
Figure 4.6– PbSAMS localises to parasite cytosol during the mosquito-stages: oocysts and sporozoites. Widefield 
microscopy images of PbSAMS-GFP oocysts and sporozoites, analysed at day 12 and 21 post infection, respectively. PbSAMS 
localisation was assessed using the anti-GFP antibody and PbHSP70 was used to stain Plasmodium cytosol. DAPI was used for 
nuclei staining. Scale bar - 5 µm  
 
 
Extending the localisation studies to the exo-erythrocytic form of the parasite (liver-stage of parasite 
development), PbSAMS-GFP-infected HepG2 hepatoma cells were fixed at developmentally relevant 
time points and an IFA was performed. Fluorescence microscopy analysis upon staining with the anti-
GFP antibody showed that, similarly to the mosquito-stage, PbSAMS co-localises with the PbHSP70 
(Figure 4.7). Altogether, these data show that PbSAMS enzyme is expressed throughout all stages of 
Plasmodium life cycle, localising to the parasite cytosol. 
 
 
 
 
 
 
Figure 4.7– PbSAMS localises to parasite cytosol during the liver-stage of the development. Widefield microscopy images 
of PbSAMS-GFP parasites developing inside HepG2 cells. PbSAMS localisation was assessed at 24 hpi using the anti-GFP 
antibody. PbHSP70 was used to stain Plasmodium cytosol and DAPI was used for nuclei staining. Scale bar - 5 µm 
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2.  Effect of Pbsams knockdown in Plasmodium survival and development 
Deletion of genes that are essential for Plasmodium development during the blood-stage inescapably 
results in parasite death, hindering the characterization of the desired gene. To study the importance 
of PbSAMS throughout the life cycle we tried to knockout Pbsams gene in three independent 
transfections. Pbsams was refractory to genetic deletion in blood-stage parasites, suggesting that has 
an essential role during that stage of development. In order to overcome this limitation we recurred 
to a conditional knockdown strategy by fusion of a destabilising domain system (DD) to the SAMS 
protein. 
 
Destabilising Domain (DD) strategy 
The working principle of this technique involves a chemical-genetic approach that allows the reversible 
expression of a protein of interest by genetic fusion to a destabilising domain (DD). The destabilising 
domain is constituted by mutants of E.coli dihydrofolate reductase (ecDHFR) and was engineered to 
be degraded. This DD is inherently unstable and in the absence of a stabilising ligand, the entire fusion 
protein is misfolded and degraded by the proteasome. Despite that, in the presence of the small-
molecule ligand trimethoprim (TMP) the domain together with the entire fusion protein is stabilised, 
without affecting the target protein structure and function52,53. In this study, we worked with PbSAMS-
DD parasite lines previously obtained from two independent clonal lines. The desired construct 
containing the target gene fused to the DD, which is attached to the hemagglutinin (HA) tag, was 
introduced into P. berghei genome using a single crossover transfection strategy. After transfection, 
infected mice were treated with pyrimethamine to select a pure transgenic parasite population and 
with TMP for stabilisation of the SAMS-HA-DD fusion protein (hereafter referred to as SAMS-DD; Figure 
4.8 A). Confirmation of the integration of the transgenic locus containing the 3’-HA-DD into the desired 
genome loci and confirmation of WT parasites removal was performed by genotyping PCR (Figure 4.8 
B). Following the successful generation of the cloned transgenic P. berghei lines expressing the 
PbSAMS-DD fusion protein, we analysed PbSAMS role in P. berghei growth and development during 
the different stages of the life cycle. 
 
 
Figure 4.8 – Pbsams gene is essential during the blood-stage of infection hindering gene deletion. (A) Schematic 
representation of the Destabilising Domain strategy (DD) for Pbsams knockdown by single crossover recombination. (B) 
Genotyping PCR confirming a clonal population of PbSAMS-DD parasites. Lane 1: detection of WT Pbsams locus; Lane 2: 
detection of knockdown integration locus; Lane 3: DNA quality control 
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2.1 SAMS is essential during the blood-stage development of Plasmodium     
To assess the effect of PbSAMS knockdown through destabilisation of the SAMS-DD protein in the 
outcome of the infection, Balb/c and C57BL6/J mice were infected through i.v. injection of 103 
PbSAMS-DD sporozoites and parasitemia was followed daily. It has been described that a successful 
DD-stabilisation by TMP treatment in mouse tissue requires, at least, a 3-week treatment52.  Thus, 
stabilisation of the PbSAMS-DD protein was achieved by pre-treating mice with TMP, 3 weeks before 
the infection until the end of the experiment. Balb/c mice do not develop severe malaria associated 
syndrome and succumb at very high parasitemia levels, allowing the study of PbSAMS importance 
during a chronic infection. In contrast, C57BL6/J mice allowed the evaluation of the effect of PbSAMS 
destabilisation in the onset of the severe disease syndrome, cerebral malaria, and survival. The length 
of the pre-patent period – time between sporozoite inoculation and the appearance of parasites in the 
blood – directly reflects the duration of the liver-stage and the number of infective merozoites 
produced. Results obtained suggest that PbSAMS-DD destabilisation has no effect in parasites 
development during the liver-stage. This is evidenced by the appearance of both control (stabilised 
SAMS-DD; + TMP) and knockdown (destabilised SAMS-DD; - TMP) parasites in the bloodstream at the 
same day post infection - day 4 post infection, both in Balb/c and C57BL6/J mice, similarly to the WT 
parasite (Figure 4.9 A, 4.9 B).  
 
Figure 4.9 –  Blood-stage parasites rely on PbSAMS protein as its absence results in a developmental impairment.  
(A,B) Progression of parasitemia in Balb/c (A) and C57BL/6 (B) mice following infection (i.v.) with 103 WT P.berghei or 
PbSAMS-DD sporozoites, in the presence or absence of the stabilization ligand TMP. Parasitemia was determined by counting 
infected erythrocytes in Giemsa stained blood smears. (C) Survival of C57BL/6J mice infected i.v. with 103 PbSAMS-DD 
sporozoites in the presence or absence of the stabilization ligand TMP. Error bars represent the SEM. Statistical significance 
was determined by the Mann Whitney U test, *p < 0.05, **p<0.01, ***p<0.001. N=3  
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The results obtained show that PbSAMS-DD destabilisation by TMP removal leads to a decrease in 
blood parasitemias both in Balb/c and C57BL6/J mice, although the difference is more pronounced in 
Balb/c mice. By contrast, mice infected with PbSAMS-DD in the presence of TMP therefore leading to 
protein stabilisation, develop a parasitemia comparable to that of mice infected with WT parasites 
(Figure 4.9 A, B). 
Analysis of survival curves show that while all mice infected with PbSAMS-DD sporozoites in the 
presence of TMP died between day 8 and 9 post infection of cerebral malaria (CM), 8 out of 10 mice 
infected with PbSAMS knockdown parasites (- TMP) survived. Thus, PbSAMS destabilisation has an 
effect in the outcome of the infection resulting in a lower parasitemia and also in survival, providing 
some protection against this severe neurological complication (Figure 4.9 C). For all experiments 
performed with Balb/c mice, confirmation of protein stabilisation/destabilisation was performed by 
Immuno-blotting. Whole parasite extracts were obtained from blood of infected Balb/c mice collected 
10 days post infection. PbSAMS-HA-DD levels were detected using the anti-HA antibody. The PbBip 
was used as a loading control to normalize PbSAMS-DD levels and, like this, evaluate destabilisation 
levels. Destabilisation by TMP removal steeply reduced the levels of PbSAMS protein, suggesting that 
it is being degraded (Figure 4.10). These results obtained explain and reinforce the results obtained 
above, being in accordance with the marked differences obtained in parasitemia during the blood-
stage of infection. This suggests that P. berghei relies on PbSAMS to successfully complete its 
development during the blood-stage of infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 – Removal of TMP leads to PbSAMS-DD destabilisation, resulting in a decrease in PbSAMS expression levels. 
(A) Quantification of Pbsams knockdown in destabilised PbSAMS with respect to the stabilised PbSAMS protein using the HA 
antibody. Band quantification intensity was performed using the ImageJ software. PbBip intensity levels were used for 
normalization. Error bars represent SEM. Statistical significance was determined by the Mann Whitney U test, *p<0.05. (B) 
Representative picture of immuno-blotting analysis of PbSAMS-DD destabilisation in whole parasite pellet extracts from mice-
infected blood. The monoclonal mouse anti-HA antibody was employed to detect the HA-tagged PbSAMS-DD fusion protein.  
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2.2 SAMS is not essential during the mosquito-stage development of Plasmodium     
To assess the effect of PbSAMS knockdown in oocysts and sporozoites development, Anopheles 
stephensi mosquitoes were infected with WT or PbSAMS-DD parasites either in the presence (SAMS-
DD + TMP) or absence (SAMS-DD - TMP) of the stabilising ligand. Stabilisation within the mosquito 
vector was assured by supplementing mosquito food with TMP (0.50 mg /mL).  At day 12 post 
mosquito infection, midguts were dissected and oocysts were stained with mercurochrome. Oocyst 
number and size was assessed by light microscopy. Salivary glands were dissected 21 days post 
infection and the number of sporozoites obtained per mosquito was assessed. Destabilisation of 
PbSAMS protein by TMP removal did not result in any statistically significant difference in both the size 
and number of knockdown (- TMP) PbSAMS-DD oocysts, when comparing to the control (+ TMP) 
counterpart (Figure 4.11 A, 4.11 C). Sporozoites number obtained for both control (+ TMP) and 
knockdown (- TMP) PbSAMS-DD parasites are also not significantly different, suggesting that this 
protein is not essential for Plasmodium successful development within the mosquito vector as both 
oocyst number and size and sporozoites number are comparable to WT parasites (Figure 4.11 B). 
Similarly to the blood-stage of infection, levels of protein stabilisation were assessed by immuno-
blotting however, the low abundance of parasite material did not allowed the confirmation of protein 
stabilisation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 –Pbsams knockdown has no effect in PbSAMS-DD oocysts and sporozoites development in A. Stephensi 
mosquitoes. (A) Quantification of oocyst number in WT- and PbSAMS-DD-infected mosquito midguts dissected at day 12 post 
mosquito infection and stained with mercurochrome, by light microscopy. Each symbol represents an individual mosquito 
midgut. Horizontal lines represent the mean number of oocysts. (B) Quantification of sporozoites in WT- and PbSAMS-DD-
infected salivary glands dissected 21 days post mosquito infection. Error bars represent the SEM. (C) Representative image 
of oocysts size in mosquito midguts infected with WT (left panel) or PbSAMS-DD parasites, on stabilisation (central panel) 
and destabilisation (right panel) of PbSAMS.  Scale bar – 100 µm. Statistical significance was determined by the Mann Whitney 
U test, p>0.05. N=3 
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2.3 SAMS is not essential during the liver-stage development of Plasmodium 
The effect of PbSAMS knockdown during Plasmodium liver-stage of infection was assessed in vitro, in 
HepG2 cells. Cells were infected with PbSAMS-DD sporozoites and treated with increasing 
concentrations of the stabilising ligand, TMP (0.5 and 5 µM). Exoerythrocytic forms (EEFs) 
development was assessed by IFA using the anti-HA antibody. The results show that PbSAMS 
destabilisation does not affect infection rate, as evidenced by the similar number of EFFs produced by 
both control (+ TMP) and knockdown (- TMP) PbSAMS-DD parasites (Figure 3.12 A). Furthermore, 
results also show that parasite replication is not altered in the absence of PbSAMS, as the size of EEFs 
is similar (Figure 4.12 B).  
Figure 4.12 –  PbSAMS destabilisation by TMP removal results in a decrease of protein levels without affecting liver-stage 
parasites replication and growth, in vitro. (A-B) Quantification of the (A) number and (B)  size of PbSAMS-DD EEFs under 
different concentrations of the stabilising ligand TMP, analysed at 48 hours post infection of HepG2 cells, assessed by  
confocal microscopy. (C) Quantification of SAMS-DD levels, in EEFs developing under different TMP concentrations, by 
measuring HA fluorescence intensity. Horizontal lines represent mean fluorescence intensity for the HA-tagged PbSAMS 
protein for each group. Error bars represent the SEM. Statistical significance was determined by the Mann Whitney U test, 
**p<0.01, *** p<0.001. N=3 
 
The stabilisation of PbSAMS by TMP treatment was analysed by IFA using the anti-HA antibody and 
fluorescence intensity was quantified, allowing the measurement of PbSAMS levels and subsequently, 
of the extent of Pbsams knockdown. Data obtained show that PbSAMS levels are lower in the absence 
of TMP, suggesting that PbSAMS is being degraded (Figures 4.12 C, 4.13). In addition, results also 
suggest that TMP stabilises PbSAMS in a dose-dependent manner, as evidenced by an increased in 
fluorescence intensity when higher concentrations of TMP are added (Figure 4.12 C). 
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Figure 4.13 –  TMP removal results in a decrease of PbSAMS protein levels during in vitro liver-stage infection. Confocal 
images of PbSAMS-DD parasites developing in HepG2 cells in the presence or absence of the stabilizing ligand (TMP). PbSAMS-
DD was detected using the anti-HA antibody. The anti-UIS4 antibody was used as parasitophorous vacuole membrane marker 
and DAPI was used for nuclei staining. Scale bar - 5 µm 
 
To assess the effect of PbSAMS knockdown in Plasmodium growth and replication during hepatic 
development in vivo, C57BL/6 mice were infected with 5 x 104 PbSAMS-DD sporozoites either in the 
presence (+ TMP) or absence (- TMP) of the stabilising ligand. Thus, to ensure PbSAMS stabilisation 
during liver infection, mice were pre-treated 3 weeks before infection with TMP in drinking water 
(0.25mg/mL). Mice were kept under treatment until the end of the experiment. Livers were harvested 
48 hours after sporozoites infection (i.v.) and total RNA was extracted and converted into cDNA. 
Parasite load in the liver was quantified by RT-qPCR using specific primers to P. berghei 18S rRNA. 
Mouse hprt expression levels were used as housekeeping gene for normalization.  
  
 
Figure 4.14 –  PbSAMS destabilisation by 
TMP removal decreases protein levels 
without affecting liver infection, in vivo. (A) 
Parasite liver load in C57BL/6J mice infected 
with WT or PbSAMS-DD sporozoites, and 
treated or not with TMP. Liver load was 
measured 48hpi by RT-qPCR of P. berghei 18S 
rRNA and normalized to mouse hprt 
housekeeping gene. Each symbol represents 
an individual mouse. (B) Quantification of 
SAMS-DD levels, in EEFs developing in the 
presence or absence of TMP, by measuring 
HA fluorescence intensity Horizontal lines 
represent the mean fluorescence intensity 
for the HA-tagged PbSAMS protein for each 
group. Error bars represent SEM. Statistical 
significance was determined by the Mann 
Whitney U test, *** p<0.001. 
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Results obtained show that destabilisation of PbSAMS protein by TMP removal has no effect in parasite 
liver load, when compared to the stabilised counterpart both comparable with the WT parasite (Figure 
4.14 A), suggesting that PbSAMS does not possess a key role during Plasmodium hepatic infection.   
 
Stabilisation levels of PbSAMS by TMP treatment, in the same livers, were quantified by IFA. A liver 
lobe was fixed and subsequently sliced into 40-µM sections. HA-tagged PbSAMS levels were detected 
and quantified using the anti-HA antibody. The results obtained show that PbSAMS is stabilised when 
TMP is added, as evidenced by a marked increase in fluorescence intensity for the HA staining when 
compared to fluorescence levels obtained for the destabilised (- TMP) condition (Figures 4.14 B, 4.15).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15 - TMP removal results in a decrease of PbSAMS protein levels during in vivo liver-stage infection. Confocal 
images of PbSAMS-DD parasites developing in livers of mice treated or not withTMP. PbSAMS-DD was detected using the 
anti-HA antibody. The anti-UIS4 antibody was used as parasitophorous vacuole membrane marker and DAPI was used for 
nuclei staining. Scale bar - 5 µm 
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All parasitic infections rely on robust metabolic interactions between the parasite and its host. This 
metabolic interplay between host and parasite is the basis for the establishment of a successful 
infection as far as parasites take advantage of host nutrients to ensure their own growth and 
replication. At the same time the host needs to handle with and struggle against, toxins and tissue 
damage that arise from infection in order to maintain homeostasis. As a rapidly growing organism, 
Plasmodium heavily depends on this metabolic exchanges with the host to survive. As such, malaria 
parasites developed mechanisms to exploit host nutrients through the modulation of their metabolic 
network54. During the blood-stage of infection Plasmodium obtains methionine through haemoglobin 
degradation and simultaneous induction of NPPs in the host cell surface improving the transport and 
therefore, the uptake of this vital amino acid36. However, the mechanisms by which Plasmodium 
modulates host cells and how much the host cell contributes to parasites survival and to the 
establishment of a successful infection during the liver- and the mosquito-stage, is not described in 
detail. Since the hepatic stage of Plasmodium development is silent, occurring before the onset of the 
pathology, it is a promisor target for the development of an intervention strategy. Despite the 
availability of several therapeutic and prophylactic drugs, malaria still remains a major health 
concern. The appearance of resistance against the available drugs coupled with a scarce 
understanding of Plasmodium biology and in its interactions with the host, make this goal harder 
to reach.  Thus, the study and characterization of novel drug targets in Plasmodium parasites are 
critical to reduce the burden of malaria worldwide.  
The first step of methionine cycle is the synthesis of SAMe, the major biological methyl donor in all 
living cells. Given the unique role of the hepatocyte in SAMe synthesis - about 80% of SAMe is 
synthesized in the mammalian liver - and the importance of SAMe dependent transmethylation 
reactions in cell growth and replication we hypothesized that Plasmodium, while replicating inside 
hepatocytes, ensures its nutritional demands by scavenging this metabolite from the host cell. Inside 
hepatocytes Plasmodium undergoes an exponential replicative process, achieving one of the fastest 
growth rate among eukaryotic cells – each parasite develops into 10 to 30 000 merozoites according 
to Plasmodium spp55,56. To fulfill their metabolic requirements and to withstand this fast growth, 
parasites must scavenge nutrients from the host cell, including the essential metabolite SAMe. 
Plasmodium tropism to hepatocytes coupled with the obligatory liver-stage of infection suggests that 
the host hepatocyte plays a key role in Plasmodium development, reflecting the unique metabolic 
properties of mammalian hepatocytes.  
Data herein described show that during the blood-stage of infection Plasmodium growth and 
replication is influenced by the metabolism of methionine. We show that, PbSAMS knockdown 
parasites (PbSAMS-DD – TMP) and consequently unable to synthesize SAMe, undergo a 
developmental impairment that results in lower parasitemia in PbSAMS-DD - TMP-infected mice. 
These results suggest a role for methylation or polyamines in Plasmodium development and in the 
establishment of a successful infection during the blood-stage of infection.  
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The lower parasitemia observed may be due to Plasmodium inability to synthesize endogenous 
SAMe coupled with either: 1) an insufficient supply of SAMe by the host cell; or 2) Plasmodium 
inability to take it up from the host cell. Still, a small number of parasites can proceed with blood-
stage infection suggesting that the low amounts of SAMe produced by the host erythrocyte 
together with the fact that the DD system employed for the PbSAMS inducible knockdown strategy 
is leaky, may be sufficient to support the growth of a reduced number of parasites. Notably, our 
data show that while PbSAMS-dependent SAMe synthesis is essential for blood-stages of infection, 
it is not essential throughout other stages of P. berghei life cycle. During the liver- and in the 
mosquito-stage Plasmodium development is not affected by the lack of SAMS and consequently, 
by the low levels of SAMe, suggesting that parasites offset the lack of SAMe synthesis through its 
uptake from the host. In fact, this is quite plausible given that the hepatocyte is a privileged cell in 
terms of methionine metabolism and SAMe production. The exclusive expression of MAT I/III 
enzyme with kinetic properties that allow for the production of virtually unlimited amounts of 
SAMe19, may constitute the ideal environment for Plasmodium intense intra-hepatic replication. 
From the therapeutic point of view the methionine metabolic pathway, as an essential metabolic 
via during the blood-stage of development, may constitute a new antimalarial target. The 
treatment with an inhibitor of PbSAMS, consequently leading to inhibition of SAMe synthesis may 
result in parasite death, opening a new line of research toward the development of novel 
antimalarial therapeutics.  
Methionine is also the precursor of the antioxidant glutathione through the transsulfuration 
pathway. Plasmodium infection leads to an increased oxidative stress both in the mammalian host 
and in the mosquito vector. To ensure the maintenance of a redox equilibrium, Plasmodium evolved 
antioxidant mechanisms such as the GSH which constitutes the primary line of defense against ROS. 
Thus, we expected that parasites lacking GS (Pbgs-) due to an impaired response to the external 
oxidative stress, would face a major difficulty to grow and survive in pro-oxidative environments - 
such as the infected erythrocyte of the mammalian host and the mosquito vector. Our results 
showed that in the absence of the antioxidant GSH, Pbgs- parasites survived during the blood-stage 
of the infection, suggesting that P. berghei do not depend on the de novo synthesis of GSH to 
complete a successful asexual development. This observation suggests that P. berghei overcomes 
the lack of GSH through scavenging the host metabolite, possibly from the host erythrocyte and 
further transport to the food vacuole, via endocytic vesicles that contain haemoglobin50. While in 
the blood-stage GS deletion has a minor effect in parasites growth and survival in the mosquito 
vector it has a dramatic effect. During the mosquito-stage ROS levels are known to increase within 
the mosquito midgut as a consequence of: 1) the innate immune response of the vector to 
Plasmodium infection and also due to 2) Plasmodium switching from glycolysis to oxidative 
phosphorylation to obtain energy, resulting in an increased mitochondrial activity and 
consequently, in the production of large amounts of ROS. Additionally, oocysts development occurs 
extracellularly which results in an increased vulnerability to these reactive species during that stage 
of development.  
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Results obtained suggest that a fully functional GSH antioxidant system is essential, as parasites 
lacking GS and therefore, unable to synthesize GSH may not be able to deal with this increased 
oxidative stress.57  Thus, an increased demand for this tripeptide during that stage of development 
coupled with an insufficient supply of GSH by the host results in parasite death during oocysts 
development. In fact, the majority of anti-malarial drug therapies against blood-stages, namely 
chloroquine, primaquine and derivates of artemisin, promote oxidation through mechanisms that 
induce the production of free radicals. Increasing ROS levels within the mosquito midgut and blocking 
Plasmodium GSH biosynthetic pathway may constitute a promising tool to prevent parasite survival 
and spreading as: 1) Pbgs- parasites are not able to develop into infectious sporozoites, preventing the 
transmission from the mosquito vector to the mammalian host; and 2) the developmental arrest at 
the oocyst stage is not rescued by mosquito blood feeding on mice. As an essential via during the 
mosquito-stage, treatment with an irreversible inhibitor of P. berghei GSH synthesis may be a 
promising approach to develop novel transmission-blocking strategies. Due to its essentiality during 
the mosquito-stage, characterization of P. berghei GS enzyme during the liver-stage has been specially 
challenging. The inability to produce Pbgs- sporozoites compromised the transmission from the 
mosquito vector to the mammalian, preventing further characterization of the role of GS during the 
liver-stage of development. To overcome this limitation further studies are needed focusing either to 
1) inhibition of Plasmodium switching from glycolysis to oxidative phosphorylation during the 
mosquito-stage of development, ensuring a low level of ROS; or 2) generation of Pbgs-lacking parasites 
through inducible knockdown which will allow us to specifically silence our gene of interest after 
sporozoites production.  
Altogether, the results obtained in this study identify potentially relevant targets for the development 
of antimalarial drugs pointing either to the blood-stage (PbSAMS), preventing the progression of 
disease and further relapsing (via P. vivax) and to the mosquito-stage (PbGS), preventing the 
differentiation of sexual parasites into thousands of infective sporozoites, hindering transmission from 
the vector to the mammalian host with potential to substantially reduce the spread of the disease.  
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 ANNEXES 
1. Primers List and Sequence: 
 
Supplementary table 1 -  List of primers used in PCR and RT-qPCR reactions  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
